Tel:
Fax:
Email:
Creative Biolabs

NeuroMab™ Anti-LAG3 BBB Shuttle Antibody(NRZP-1022-ZP3026)

[CAT#: NRZP-1022-ZP3026]

Host Species:
Humanized
Species Reactivity:
Human
Applications:
ELISA; Inhib; In Vitro

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Humanized

Applications

ELISA; Inhib; In Vitro

Relevant Diseases

Parkinson's Disease
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

LAG3

Official Name

LAG3

Full Name

lymphocyte-activation gene 3

Alternative Names

CD antigen CD223; CD223; Protein FDC; Lymphocyte activation gene 3 protein; LAG-3
Product Pictures
ELISA

Figure 1 ELISA results showing EC50 of antibody binding to LAG3 intact extracellular domain (D1-D4 huFc) but not D1-D2 deleted LAG3 (△D1-D2 huFc).

Inhib

Figure 2 Dose-dependent inhibition of the binding of LAG3 to its receptor MHC class II molecules.

FuncS

Figure 3 122H, 147H, and 170H mouse mAbs dose-dependently promote IL2 production by Jurkat T cells.

FuncS

Figure 4 Humanized monoclonal antibody 147H-13 dose-dependently promotes the production of IL2 by Jurkat T cells.

FuncS

Figure 5 Effect of affinity matured anti-LAG3 antibody on stimulation of IL2 release from Jurkat T cells.

Block

Figure 6 Anti-LAG3 antibody blocks the binding of Galectin-3 or LSECtin to LAG3.

Block

Figure 7 The combination of anti-LAG3 antibody and anti-PD-L1 antibody produced significantly more IL-2 than each alone.

Block

Figure 8 Combination of anti-PD-L1 antibody and 147H-13 shows strong inhibition of MC38 tumor growth.

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar

The Spectrum of Stem Cell-Based Neuronal Models and Their Fit for Purpose

2:00 PM–3:00 PM EST, December 12, 2024

REGISTER NOW
Inquiry Basket
compare

Send inquiry